rewirebio.iobenchmarks
Protocol

Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, full panel: multinomial phenotype AUROC

Panel fragmentomic metrics computed on all genes of the cohort's panel; one multinomial model per metric predicts Breast, Lung, Normal, Prostate.

13 evaluations · 65 results

Overview

An explanatory profile has not yet been reviewed for this record.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

13 recorded evaluations, 65 metric rows. A comparison chart has not yet been validated for these results. The table retains the individual findings and their sources.

View coverage and remaining gaps across all benchmarks

Results

Results are available, but no reviewed comparison panel is linked in this release.

All evaluations

13 evaluations · 65 results. Different protocols are not a single leaderboard.

Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, full panel: multinomial phenotype AUROC · Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)

Sorted by AUROC (Breast vs all other classes, one-vs-rest, median of 25 replicates; Full panel genes) (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.

Tested configurationAUROC (Breast vs all other classes, one-vs-rest, median of 25 replicates; Full panel genes)AUROC (healthy (Normal) vs all cancers, one-vs-rest, median of 25 replicates; Full panel genes)AUROC (Lung vs all other classes, one-vs-rest, median of 25 replicates; Full panel genes)AUROC (mean over 4 phenotypes of the median one-vs-rest AUROCs; Full panel genes)AUROC (Prostate vs all other classes, one-vs-rest, median of 25 replicates; Full panel genes)
Normalised fragment read depth at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Evaluation0.958 (best in column)1 (best in column)0.9140.964 (best in column)0.986 (best in column)
Normalised fragment read depth at first coding exons, GLMnet multinomial classifier (Helzer et al. 2025)Evaluation0.9571 (best in column)0.9090.9610.977
All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Evaluation0.9451 (best in column)0.8940.9560.983
End-motif diversity score at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Evaluation0.9450.9990.8930.9510.968
Fragment-size Shannon entropy at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Evaluation0.9420.9990.915 (best in column)0.9590.983
Small-fragment proportion at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Evaluation0.9320.9940.8980.9440.951
Normalised fragment read depth per gene, GLMnet multinomial classifier (Helzer et al. 2025)Evaluation0.931 (best in column)0.8770.9470.98
Fragment-size entropy at transcription factor binding sites, GLMnet multinomial classifier (Helzer et al. 2025)Evaluation0.9280.9990.8710.9420.971
Fragment-size Shannon entropy at first coding exons, GLMnet multinomial classifier (Helzer et al. 2025)Evaluation0.910.9920.8850.9380.968
End-motif diversity score at first coding exons, GLMnet multinomial classifier (Helzer et al. 2025)Evaluation0.9040.9990.8330.9220.951
Small-fragment proportion at first coding exons, GLMnet multinomial classifier (Helzer et al. 2025)Evaluation0.8870.9910.8790.920.925
Fragment-length bin proportions at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Evaluation0.8760.990.8260.9110.953
Fragment-size entropy at cancer-specific open chromatin, GLMnet multinomial classifier (Helzer et al. 2025)Evaluation0.7870.9510.7980.8530.875
All 65 result rows with coverage, uncertainty and sources
Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, full panel: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.945 AUROC (Breast vs all other classes, one-vs-rest, median of 25 replicates; Full panel genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail full (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-full

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Full panel', row 'All Combined', column 'Breast'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, full panel: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.894 AUROC (Lung vs all other classes, one-vs-rest, median of 25 replicates; Full panel genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail full (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-full

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Full panel', row 'All Combined', column 'Lung'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, full panel: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.956 AUROC (mean over 4 phenotypes of the median one-vs-rest AUROCs; Full panel genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail full (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-full

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Full panel', row 'All Combined', column 'Mean AUROC'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, full panel: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
1 AUROC (healthy (Normal) vs all cancers, one-vs-rest, median of 25 replicates; Full panel genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail full (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-full

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Full panel', row 'All Combined', column 'Normal'
Configuration: All panel fragmentomic metrics combined, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, full panel: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.983 AUROC (Prostate vs all other classes, one-vs-rest, median of 25 replicates; Full panel genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Combined on grail full (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-full

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Full panel', row 'All Combined', column 'Prostate'
Configuration: Normalised fragment read depth at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, full panel: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.958 AUROC (Breast vs all other classes, one-vs-rest, median of 25 replicates; Full panel genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons Depth on grail full (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-full

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Full panel', row 'All Exons Depth', column 'Breast'
Configuration: Normalised fragment read depth at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, full panel: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.914 AUROC (Lung vs all other classes, one-vs-rest, median of 25 replicates; Full panel genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons Depth on grail full (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-full

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Full panel', row 'All Exons Depth', column 'Lung'
Configuration: Normalised fragment read depth at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, full panel: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.964 AUROC (mean over 4 phenotypes of the median one-vs-rest AUROCs; Full panel genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons Depth on grail full (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-full

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Full panel', row 'All Exons Depth', column 'Mean AUROC'
Configuration: Normalised fragment read depth at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, full panel: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
1 AUROC (healthy (Normal) vs all cancers, one-vs-rest, median of 25 replicates; Full panel genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons Depth on grail full (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-full

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Full panel', row 'All Exons Depth', column 'Normal'
Configuration: Normalised fragment read depth at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, full panel: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.986 AUROC (Prostate vs all other classes, one-vs-rest, median of 25 replicates; Full panel genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons Depth on grail full (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-full

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Full panel', row 'All Exons Depth', column 'Prostate'
Configuration: End-motif diversity score at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, full panel: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.945 AUROC (Breast vs all other classes, one-vs-rest, median of 25 replicates; Full panel genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons MDS on grail full (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-full

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Full panel', row 'All Exons MDS', column 'Breast'
Configuration: End-motif diversity score at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, full panel: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.893 AUROC (Lung vs all other classes, one-vs-rest, median of 25 replicates; Full panel genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons MDS on grail full (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-full

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Full panel', row 'All Exons MDS', column 'Lung'
Configuration: End-motif diversity score at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, full panel: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.951 AUROC (mean over 4 phenotypes of the median one-vs-rest AUROCs; Full panel genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons MDS on grail full (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-full

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Full panel', row 'All Exons MDS', column 'Mean AUROC'
Configuration: End-motif diversity score at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, full panel: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.999 AUROC (healthy (Normal) vs all cancers, one-vs-rest, median of 25 replicates; Full panel genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons MDS on grail full (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-full

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Full panel', row 'All Exons MDS', column 'Normal'
Configuration: End-motif diversity score at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, full panel: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.968 AUROC (Prostate vs all other classes, one-vs-rest, median of 25 replicates; Full panel genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons MDS on grail full (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-full

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Full panel', row 'All Exons MDS', column 'Prostate'
Configuration: Fragment-size Shannon entropy at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, full panel: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.942 AUROC (Breast vs all other classes, one-vs-rest, median of 25 replicates; Full panel genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Exons SE on grail full (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-full

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Full panel', row 'All Exons SE', column 'Breast'
Configuration: Fragment-size Shannon entropy at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, full panel: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.915 AUROC (Lung vs all other classes, one-vs-rest, median of 25 replicates; Full panel genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Exons SE on grail full (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-full

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Full panel', row 'All Exons SE', column 'Lung'
Configuration: Fragment-size Shannon entropy at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, full panel: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.959 AUROC (mean over 4 phenotypes of the median one-vs-rest AUROCs; Full panel genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Exons SE on grail full (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-full

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Full panel', row 'All Exons SE', column 'Mean AUROC'
Configuration: Fragment-size Shannon entropy at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, full panel: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.999 AUROC (healthy (Normal) vs all cancers, one-vs-rest, median of 25 replicates; Full panel genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Exons SE on grail full (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-full

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Full panel', row 'All Exons SE', column 'Normal'
Configuration: Fragment-size Shannon entropy at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, full panel: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.983 AUROC (Prostate vs all other classes, one-vs-rest, median of 25 replicates; Full panel genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

All Exons SE on grail full (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-full

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Full panel', row 'All Exons SE', column 'Prostate'
Configuration: Small-fragment proportion at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, full panel: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.932 AUROC (Breast vs all other classes, one-vs-rest, median of 25 replicates; Full panel genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons Small Fragments on grail full (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-full

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Full panel', row 'All Exons Small Fragments', column 'Breast'
Configuration: Small-fragment proportion at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, full panel: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.898 AUROC (Lung vs all other classes, one-vs-rest, median of 25 replicates; Full panel genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons Small Fragments on grail full (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-full

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Full panel', row 'All Exons Small Fragments', column 'Lung'
Configuration: Small-fragment proportion at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, full panel: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.944 AUROC (mean over 4 phenotypes of the median one-vs-rest AUROCs; Full panel genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons Small Fragments on grail full (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-full

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Full panel', row 'All Exons Small Fragments', column 'Mean AUROC'
Configuration: Small-fragment proportion at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, full panel: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.994 AUROC (healthy (Normal) vs all cancers, one-vs-rest, median of 25 replicates; Full panel genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons Small Fragments on grail full (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-full

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Full panel', row 'All Exons Small Fragments', column 'Normal'
Configuration: Small-fragment proportion at each panel exon, GLMnet multinomial classifier (Helzer et al. 2025)Protocol: Helzer et al. 2025 Razavi et al. 2019 GRAIL cohort, full panel: multinomial phenotype AUROC
Dataset: Razavi et al. 2019 GRAIL targeted cfDNA cohort as used by Helzer et al. 2025 (198 samples)
0.951 AUROC (Prostate vs all other classes, one-vs-rest, median of 25 replicates; Full panel genes)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

All Exons Small Fragments on grail full (Helzer et al. 2025)

ctdnalit-20261011-helzer2025-protocol-grail-full

Aggregation: Not reported

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels; Helzer et al. 2025, Supplementary Information (Figures S1-S7, Tables S1-S2) · Supplementary Table S1 (PDF caption), block 'Full panel', row 'All Exons Small Fragments', column 'Prostate'

Source checking is not independent reproduction. Release 2026-11-21-adc15377fab2.

Methods and evaluation design

Procedure, tasks and evaluated configurations

Recorded evaluations

Each evaluation records what was tested and under which conditions.

Explore all linked results

Baseline coverage

Reference methods help show what a model adds beyond simple controls. We track a null control and a conventional method for each protocol.

0 of 2 active baseline roles have published Rewire measurements in this release. Measurements on a selected protocol do not establish coverage of an entire suite.

No execution recipe linked to this protocol. Recipe availability does not establish a completed evaluation.

Author-reported evaluations
3
External evaluations
10

Literature evidence is not a Rewire measurement. Executed but unpublished runs and private review status are not included.

Null control

Proposed control: requires review

Select a task-valid null control after reviewing inputs and metric

Protocol-specific applicability, permitted inputs, access, split, evaluator and execution requirements need review before implementation or execution.

This is a suggested selection rule, not a validated method or a measured score.

Conventional reference

Proposed control: requires review

Select an upstream conventional reference after reviewing the full protocol

Protocol-specific applicability, permitted inputs, access, split, evaluator and execution requirements need review before implementation or execution.

This is a suggested selection rule, not a validated method or a measured score.

Protocol coverage CSV (gzip) · Model evaluation matrix (gzip) · Source table (gzip) · Release and checksums (gzip)

Coverage is derived from release 2026-11-21-adc15377fab2. Source citations describe the original records; they do not validate an unreviewed baseline proposal. No results have been generated by this audit.

Run instructions

No runnable recipe has been reviewed for this protocol. Dataset access, model requirements, licences and compute requirements must be checked against its sources before execution.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

0 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-adc15377fab2
Property and statementOriginal source and locationReview and provenance

No evidence rows match these filters. Choose another scope or clear the search.

Sources and history

Release 2026-11-21-adc15377fab2 · Record review: source checked

2 source records and release historyDownload this release (gzip)
Technical metadata and record identifiers

Technical metadata for this record is tracked under stable ID ctdnalit-20261011-helzer2025-protocol-grail-full.

Source locator: Supplementary Table S1; Results P7-P12; Methods P23

Related records

Suggest a correction